ÂÜÀòÂÒÂ×

Joachim Greuel is a highly experienced professional in the fields of finance, healthcare management, and biotechnology. Currently serving as Managing Director at Bioscience Valuation since October 2000, Joachim has held various notable positions, including Professor of Finance and Healthcare Management at IE Business School (2011-2013) and Investment Manager at NMT New Medical Technologies AG (1998-2000). Previous experience includes roles as a Senior Strategy Consultant at Accenture (1995-1997) and Head of Neurophysiological Research at Bayer (1988-1993). Joachim holds an MBA in Finance and Healthcare Management from The Wharton School and a Ph.D. in Physiology from the Max-Planck-Institute for Brain Research and Eberhard Karls University of Tübingen, along with a Master/Diplom in Biology from The Philipp University of Marburg.